Photo of Ilya Tsimafeyeu taken from bucare.org
Oct 25, 2023, 17:52
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer Research Russia, shared on Facebook:
“Our study: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival.”
For further information click here.
Source: Ilya Tsimafeyeu/Facebook